Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
Holding CTXR?
Track your performance easily

Citius Pharmaceuticals (CTXR) Financial Statements

1,569 Followers

Citius Pharmaceuticals Financial Overview

Citius Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.244; its P/E ratio is -1.47; Citius Pharmaceuticals is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.43M$ 13.54M$ -9.34M$ -9.80M$ -8.34M
EBITDA$ -10.38M$ 13.59M$ -9.29M$ -9.75M$ -8.29M
Net Income Common Stockholders$ -10.89M$ -8.54M$ -9.23M$ -11.10M$ -8.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 17.91M$ 12.56M$ 20.35M$ 26.48M$ 33.28M
Total Assets$ 97.09M$ 90.71M$ 97.40M$ 103.61M$ 110.40M
Total Debt$ 320.01K$ 374.83K$ 428.57K$ 481.25K$ 532.88K
Net Debt$ -17.59M$ -12.18M$ -19.92M$ -26.00M$ -32.75M
Total Liabilities$ 10.81M$ 10.74M$ 12.07M$ 12.18M$ 12.10M
Stockholders Equity$ 85.68M$ 79.37M$ 84.73M$ 90.83M$ 97.70M
Cash Flow-
Free Cash Flow$ -8.37M$ -7.79M$ -6.14M$ -6.80M$ -9.58M
Operating Cash Flow$ -8.37M$ -7.79M$ -6.14M$ -6.80M$ -9.58M
Investing Cash Flow-----
Financing Cash Flow$ 13.72M--$ -687.00$ 13.80M
Currency in USD

Citius Pharmaceuticals Earnings and Revenue History

Citius Pharmaceuticals Debt to Assets

Citius Pharmaceuticals Cash Flow

Citius Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis